Shukra Pharmaceuticals to Rebrand as Shukra Medtech Limited

Shukra Pharmaceuticals Limited announced its Board of Directors has approved a proposal to change the company's name to Shukra Medtech Limited. This rebranding is accompanied by an expansion of its main objects clause to include activities in the Medical Technology (MedTech) sector. The move aims to broaden the company's corporate identity and enable exploration of new business opportunities in MedTech, complementing its existing pharmaceutical and healthcare operations. The changes are subject to shareholder approval and necessary regulatory clearances from authorities like the Registrar of Companies and SEBI.